These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27260085)

  • 1. The development of a peak-time criterion for designing controlled-release devices.
    Simon L; Ospina J
    Eur J Pharm Sci; 2016 Aug; 91():64-73. PubMed ID: 27260085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of dissolution and diffusion-controlled drug release systems.
    Simon L; Bolisetty P; Erazo MN
    Curr Drug Deliv; 2011 Mar; 8(2):144-51. PubMed ID: 21235474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timely drug delivery from controlled-release devices: dynamic analysis and novel design concepts.
    Simon L
    Math Biosci; 2009 Feb; 217(2):151-8. PubMed ID: 19059271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a mixed-effect pharmacokinetic model for vehicle modulated in vitro transdermal flux of topically applied penetrants.
    Chittenden JT; Brooks JD; Riviere JE
    J Pharm Sci; 2014 Mar; 103(3):1002-12. PubMed ID: 24481625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2001 Apr; 90(4):504-20. PubMed ID: 11170040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added release time in diffusion/dissolution coupled release.
    Nuxoll E
    Int J Pharm; 2015 Oct; 494(1):195-204. PubMed ID: 26276252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycaprolactone thin-film drug delivery systems: Empirical and predictive models for device design.
    Schlesinger E; Ciaccio N; Desai TA
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():232-9. PubMed ID: 26354259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery.
    Rim JE; Pinsky PM; van Osdol WW
    Ann Biomed Eng; 2005 Oct; 33(10):1422-38. PubMed ID: 16240090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical models for calculating the blood level of a drug with oral controlled release forms.
    Vergnaud JM
    Medinfo; 1995; 8 Pt 2():1127-31. PubMed ID: 8591386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization.
    Alvarado HL; Abrego G; Souto EB; Garduño-Ramirez ML; Clares B; García ML; Calpena AC
    Colloids Surf B Biointerfaces; 2015 Jun; 130():40-7. PubMed ID: 25899842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration.
    Shamma RN; Basalious EB; Shoukri RA
    Int J Pharm; 2011 Feb; 405(1-2):102-12. PubMed ID: 21145958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling of drug dissolution.
    Siepmann J; Siepmann F
    Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems.
    Peppas NA; Narasimhan B
    J Control Release; 2014 Sep; 190():75-81. PubMed ID: 24998939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.